Lead articles

Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management

Rehab Al Harbi, Iain A McNeish, Mona El-Bahrawy

10.1136/ijgc-2020-002018

January 7, 2021

Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB–IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study

Simone Marnitz, Audrey Tieko Tsunoda, Peter Martus, Marcelo Vieira, Renato Jose Affonso Junior, João Nunes, Volker Budach, Hermann Hertel, Alexander Mustea, Jalid Sehouli, Jens-Peter Scharf, Uwe Ulrich, Andreas Ebert, Iris Piwonski, Christhardt Kohler

10.1136/ijgc-2020-001973

December 8, 2020

Urinary diversion after pelvic exenteration for gynecologic malignancies

Carlos Martínez-Gómez, Martina Aida Angeles, Alejandra Martinez, Bernard Malavaud, Gwenael Ferron

10.1136/ijgc-2020-002015

November 23, 2020

Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-)

Anna Fagotti, Maria Gabriella Ferrandina, Giuseppe Vizzielli, Tina Pasciuto, Francesco Fanfani, Valerio Gallotta, Pasquale Alessandro Margariti, Vito Chiantera, Barbara Costantini, Salvatore Gueli Alletti, Francesco Cosentino, Giovanni Scambia

10.1136/ijgc-2020-001640

October 7, 2020

Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: an international survey of peri-operative practice

Geetu Prakash Bhandoria, Prashant Bhandarkar, Vijay Ahuja, Amita Maheshwari, Rupinder K Sekhon, Murat Gultekin, Ali Ayhan, Fuat Demirkiran, Ilker Kahramanoglu, Yee-Loi Louise Wan, Pawel Knapp, Jakub Dobroch, Andrzej Zmaczyński, Robert Jach, Gregg Nelson

10.1136/ijgc-2020-001683

August 4, 2020

Clinical patterns and genomic profiling of recurrent ‘ultra-low risk’ endometrial cancer

Marina Stasenko, Noah Feit, Simon S K Lee, Cassandra Shepherd, Robert A Soslow, Karen A Cadoo, Kaled Alektiar, Edaise M Da Silva, Ana Paula Martins Sebastião, Mario M Leitao Jr, Ginger Gardner, Pier Selenica, Nadeem R Abu-Rustum, Britta Weigelt, Jennifer J Mueller

10.1136/ijgc-2020-001241

May 5, 2020

Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events

Ainhoa Madariaga, Valerie Bowering, Soha Ahrari, Amit M Oza, Stephanie Lheureux

10.1136/ijgc-2020-001288

April 9, 2020

Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin

Lilie L Lin, David S Lakomy, Matthew S Ning, Fiona Simpkins, Anuja Jhingran

10.1136/ijgc-2020-001227

March 18, 2020

Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy

Jeremie Abitbol, Walter Gotlieb, Ziggy Zeng, Agnihotram Ramanakumar, Roy Kessous, Liron Kogan, Valerie Pare-Miron, Marcelo Rombaldi, Shannon Salvador, Beste Kucukyazici, Sonya Brin, Jeffrey How, Susie Lau

10.1136/ijgc-2019-000413

October 9, 2019

A proposal for a new classification of “unfavorable risk criteria” in patients with stage I endometrial cancer

Richard Li, Ashwin Shinde, Ernest Han, Stephen Lee, Sushil Beriwal, Matthew Harkenrider, Mitchell Kamrava, Yi-Jen Chen, Scott Glaser

10.1136/ijgc-2019-000264

September 1, 2019